April 2013 FDA Recall Drug by Affirm Xl, Inc.
D-015-2014 - Marketed Without An Approved NDA/ANDA

This Class I drug recall was voluntarily initiated by Affirm Xl, Inc. on April 10, 2013 for the product Drug. The FDA reported the reason for recall as marketed without an approved nda/anda. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-015-2014

Reason for Recall
Marketed Without An Approved NDA/ANDA: FDA analysis found the product to contain sulfoaildenafil, an analogue of sildenafil which is an ingredient in an FDA-approved drug for the treatment of male erectile dysfunction, making this an unapproved new drug.
Initiated
04-10-2013
Reported
11-27-2013
Quantity
400 pills

Recall Profile & Regulatory Data

Class I - is a situation in which there is a reasonable probability that the use of, or exposure to, a violative product will cause serious adverse health consequences or death.
Nationwide in the US and Canada
Affirm XL Nutritional Supplement, 1 and 10 count blister packs and single pill packs, Manufactured by Dongseo Biopharm Corp., Yongin City, Kyonggi do, Korea, distributed by: Affirm XL, LLC, Ladera Ranch, CA

Batch or Lot Expiration Information

Lot# 1190001, exp 12/30/2013